All Stories

  1. Risk Stratification in Pulmonary Hypertension in the UAE
  2. Diagnosis and Management of Group 3 Pulmonary Hypertension in the UAE: Pulmonary Hypertension Associated with Chronic Lung Disease (PH-CLD)
  3. Group 5 PH: Diagnosis and Management of Pulmonary Hypertension in Patients with a Focus on Chronic Haemolytic Diseases in the UAE
  4. Diagnosis and Management of Group 2 Pulmonary Hypertension Due to Left Heart Disease in the UAE
  5. Diagnosis and Management of Group 1 Pulmonary Arterial Hypertension in the UAE
  6. Diagnosis and Management of the Connective Tissue Disease-associated PAH in the UAE
  7. Diagnosis and Management of Group 4 PH (Chronic Thromboembolic Pulmonary Hypertension (CTEPH)) in the UAE
  8. A Review of Stem Cell Therapy in Ischemic Heart Disease, Where are We Now?
  9. A Systematic Review of Randomized Clinical Trials on the Efficacy and Safety of Pitavastatin
  10. Prevalence of Cardiovascular Risk Factors and 10-Years Risk for Coronary Heart Disease in the United Arab Emirates
  11. Perspective on the Role of Four Beta-blockers in Heart Failure
  12. Glucagon-like Peptide-1 Receptor Agonists Cardio-protective Effects: An Umbrella Review
  13. The role of Direct Oral Anticoagulant in patients with Acute Coronary Syndrome on single or dual antiplatelet regime: review of opportunities and challenges